Lenz HJ, Van Cutsem E, Luisa Limon M, Wong KYM, et al. First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study. J Clin Oncol 2021 Oct 12:JCO2101015. doi: 10.1200/JCO.21.01015.
PMID: 34637336